A new cell culture supplement, platelet lysate, was evaluated with reference to fetal bovine serum (FBS), an established industrial medium for animal cell culture. Chemical and bacteriological profiles were conducted including the presence of platelet-derived growth factor (PDGF). PDGF was detected in the platelet lysate but it was not present in FBS. The platelet lysate medium demonstrated lack of microorganisms, mycoplasma and endotoxins. The platelet lysate was investigated in culture studies (cell growth, viability and product formation) towards a number of target cells including myelomas, hybridomas, hepatocytes, fibroblasts and epithelial cells. In general the platelet lysate medium supported cell growth and maintained viabilities comparable or superior to fetal bovine serum. Productivity studies of antibodies (hybridomas) and transferrin (hepatocytes) showed similar or enhanced production in platelet-derived medium in comparison with FBS.
Introduction
Culture of animal cells is a key operation in bioscience whether it is related to research at universities or industrial production of pharmaceuticals with the help of gene technology. The cell culturist is dependent on the use of serum, mostly fetal bovine serum, for growth and product expression (Hodgson 1995) . In general serum is complex and contains numerous components required for cell culture. In fact much of the early work on cell nutrition was performed on dialyzed serum. Therefore the focus has been directed towards serum as a product for supplementing cell growth. Fetal bovine serum is the most widely used serum for animal cell culture, mainly due to its high concentration of growth stimulatory factors and low concentration of immunoglobulins. However, there are several problems with the use of serum such as availability, cost, non-desirable components, variations between batches and complications of the purification of products. Furthermore, unborn calves may be seen as an odd and perhaps ethically questionable source.
In the last decade there has been ongoing research towards alternatives to serum-based media to overcome problems associated with the use of serum. Considerable efforts have been made to reduce or eliminate serum proteins, especially during scale-up of cell-culture. Developments towards reduced-and serum-free media, chemically defined media, maintenance media and suspension culture media for anchorage-dependent cell lines have been realized (Lebkowski et al. 1995; Moreira et al. 1995; Chen et al. 1996; Tezel and Priore 1998) . Despite the abundance of new more or less defined formulations, they have only to a limited extent replaced serumbased media to date. The reasons for this are not entirely obvious but high cost, lack of availability and major differences between cell lines in nutritional requirements are all contributing factors.
Earlier work by Holmqvist and Westermark (1989) defined that a platelet fraction from animal sources could be a growth medium for animal cell culture. The platelet is present in blood at high concentrations (0.1-0.25% (w/w)). The role of the platelet is to aggregate at a site of injury and assist in the clotting mechanism and releasing growth factors as well as other mediators to start the healing process of the wound. This is achieved by allowing connective tissue to grow and stimulate the vascularisation process. Platelets are the primary source of a number of growth factors (Sporn and Roberts 1989; Ross and Raines 1990) as well as attachment factors (fibronectin and vitronectin), enzymes, serotonin and other factors for example platelet factor-4 (PF-4). Of special importance is the concentrated supply of plateletderived growth factor (PDGF) (Ross and Raines 1990) and transforming growth factor-(TGF-) (Fukimizu and Grinell 1990) . These two growth factors play an important role in cell culture as they are participating in many diverse cellular functions.
The purpose of this study has been to characterize the components of a platelet lysate medium from bovine blood and to demonstrate its potential as a growth-promoting supplement in comparison with the established industrial standard, fetal bovine serum. A number of cells was investigated including myelomas, hybridomas, hepatocytes, fibroblasts and epithelial cells.
Materials and methods

Production of platelet lysate
According to Holmqvist and Westermark (1989) , a concentrated platelet lysate is obtained from cell-rich plasma of bovine whole blood. It contains mainly of lysed platelets and can be used alone or in combination with other nutrient substrates. Briefly according to the development of Holmqvist and Westermark (1989) , the platelets are collected from whole blood in a two-step centrifugation procedure. The precipitate is then lysed with water and coagulated with CaCl 2 . After another centrifugation, the platelet lysate is sterile filtered through 0.2 m and is then ready for use. Platelet lysate was stored frozen at À18 C.
Analyses of platelet lysate
A clinical-chemical analysis (Integra 700, Roche Diagnostica, Basel, Switzerland) was used to determine the amount of phosphate, albumin, total protein, sodium, potassium, iron and glucose in platelet lysate and fetal bovine serum (FBS) . The platelet lysate was tested for Escherichia coli and Staphylococcus aureus by measuring the number of colonies on agar plates/films according to standard microbiological procedures (Nordic Committee on Food Analysis: No. 147 (1993) and 66 (1999) ). The PDGF content was determined according to Fredriksson et al. (2002) . The endotoxin content of the platelet lysate and FBS were determined with a limulus assay (Pyrogen Plus, BioWhittaker, Walkersville, USA). The samples were analyzed in duplicates with positive and negative reference samples, according to the manufacturer's recommendation. The EZ-PCR Mycoplasma Test kit (Biological Industries Co., Haemek, Israel) was used for the mycoplasma analysis according to the manufacturer's recommendations. The IgG content of the platelet lysate and FBS was analyzed by chromatography of 10 ml samples on protein G-Sepharose 4 Fast Flow: 5 ml, 5 Â 0.8 cm (Amersham BioSciences,Uppsala,Sweden),according to the manufacturer's recommendations. Sodium phosphate (0.02 M, pH 7.0) was used as binding buffer and 0.1 M glycine, pH 2.0 as elution buffer. The IgG content of the eluted fractions was detected spectrophotometrically at 280 nm.
Cell culture
The cell lines Sp2/0 (myeloma cell), 39.5 (hybridoma cell), Hel-299 (fibroblast cell), HepG 2 (hepatocytic cell) and Vero (African green monkey transformed kidney epithelial cells) were cultured at 37 C, with 7.5% CO 2 . All cell lines were obtained from ATCC except 39.5 which was provided by Dr A. Lundblad, Linkö ping University, Sweden. The cell lines were cultured in Dulbecco's Modified Eagle's Medium (DMEM) with high glucose (4.5 g l À1 ) (Sigma, St Louis, USA), 0.1% Penicillin-Streptomycin, (Life Technologies, Paisley, Scotland), 4 mM L-Glutamine, (Sigma), and growth enhancing additives: platelet lysate (5-10%), and fetal bovine serum (5%), (HyClone, Logan, USA)] in T-flasks, (Sarstedt, Newton, USA), 25-, 75-and 175 cm 2 , 5-, 15-and 35 ml, respectively. A typical growth study lasted 6-15 days. Cells were seeded, unless otherwise mentioned, in triplicates, in concentrations of 4-5 Â 10 4 cells ml À1 (1.6-2.0 Â 10 3 cells cm À2 ) in T 25 flasks. Adherent cells were counted every 24 h and suspension cells every 12 h. Adherent cells were harvested by trypsinization. Trypsin-EDTA (0.5 g l À1 porcine Trypsin, 0.2 g l À1 EDTA) (Sigma), was added, 2 Â 3 ml, at 20 C and 37 C for 1 and 2 min, respectively, in T 75 flasks.
The possibility of long-term storage of cells (liquid nitrogen) cultured in platelet lysate was analyzed. Vero cells were frozen in freezing medium of platelet lysate with 10% dimethylsulfoxide (DMSO), (Merck, Whitehouse station, USA). Briefly the cells were trypsinized, centrifuged (300 Â g, 3 min, 20 C) and freezing medium was added. The cells are then exposed to À80 C (up to 7 days) before transferred to liquid nitrogen.
The minimal seeding concentration was determined using Vero cells. The stability of the platelet lysate was analyzed during a 12-month period using Vero cells. HepG 2 cells were used for scale-up experiment. The cells were grown for 20 days in 10% platelet lysate and compared with 5% FBS in roller bottles (Sarstedt). The growth was monitored as was the production of transferrin by ELISA (see below).
Analysis of monoclonal antibody production by 39.5 cells Samples (500 l) for antibody production were taken every 12 h and analyzed by ELISA. ELISA plates (Greiner Labortechnik, Frickenhausen, Germany) were coated with Glc 4 -BSA (Glycorex AB, Lund, Sweden) (1 g ml À1 ) dissolved in 50 mM Na-carbonate, pH 9.5 (100 l). Incubation over night at 4 C was followed with blocking with 200 l bovine serum albumin (BSA) (10 g ml À1 ) in dilution buffer A (0.01 M Na-phosphate, 0.15 M NaCl, 0.1% Tween 20, pH 7.4) for 1 h at 4 C. Cell culture supernatants were diluted in dilution buffer A. Samples from the first 48 h were diluted 100 times and samples after 48 h were diluted 1000 times. The samples were applied (100 l) and the plate was incubated 4 h or overnight at 4 C. As references, 100 l of dilution buffer A was used as negative control and 100 l of purified 39.5 antibody were used as positive control. The positive control was diluted to 0.003-1.4 g ml À1 in dilution buffer A. 100 l horseradish peroxidaselabeled rabbit-anti-mouse antibody (P 260, Dakopatt, Copenhagen, Denmark), (1.3 ng ml À1 ) diluted in dilution buffer A was incubated for 2 h at 4 C. Washing procedures (0.15 M NaCl, 0.05% Tween 20) with 3 Â 300 l were performed after every incubation step except after incubation of P 260 where the washing procedure involved 4 Â 300l. The enzymatic reaction was detected with 100 l substrate (10 ml 50 mM citrate buffer pH 4.0, 40 l 50 mM H 2 O 2 and 40 l 40 mM [2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS)]), at 405 nm at 20 C with a multiscan spectrophotometer (Labsystems, Helsinki, Finland).
Analysis of transferrin production by HepG 2 cells
Samples (500 l) were taken at 24 h intervals and analyzed by ELISA. ELISA plates (Greiner Labortechnik) were coated with rabbit antihuman transferrin antibody (5 g ml À1 ) (A 0061, Dakopatt) dissolved in 50 mM Na-carbonate, pH 9.5 (100 l). Incubation overnight at 4 C was followed with blocking with 200 l bovine serum albumin (BSA) (50 g ml À1 ) in dilution buffer A for 1 h at 4 C. Cell culture supernatants were diluted 100 times in dilution buffer B (0.01 M Naphosphate, 0.15 M NaCl, 0.1% Tween 20 pH 8.0). 100 l was applied and the plate was incubated 30 min at 20 C. As references 100 l of dilution buffer B was used as negative control and 100 l of apotransferrin (Sigma) were used as positive control. The positive control was diluted to 2-100 ng ml À1 in dilution buffer B. 100 l horseradish peroxidaselabelled rabbit anti-human transferrin antibody (1.5 ng ml À1 ), diluted in dilution buffer B, was incubated for 30 min at 20 C. Washing procedures (0.15 M NaCl, 0.05% Tween 20, 3 Â 300 l) were performed after every incubation step except after incubation of horseradish peroxidase-labeled rabbit anti-human transferrin antibody where the washing procedure involved 4 Â 300 l washes. The reaction was detected with 100 l substrate (10 ml 50 mM citrate buffer pH 4.0, 40 l 50 mM H 2 O 2 and 40 l 40 mM ABTS), at 405 nm at 20 C with a multiscan spectrophotometer (Labsystems).
The cell culture was analyzed by following the production of transferrin. ELISA was performed according to the procedure above except for the supernatant sample dilution at day 16 and 20, which was 1000 times instead of 100 as for the other samples. Only single samples were analyzed since only one bottle was used per culture medium.
Results and discussion
Characterization of platelet lysate
The results from the chemical analyses are listed in Table 1 . Generally, platelet lysate medium was less complex than FBS. However, the IgG-analysis indicated an order of magnitude higher concentration in platelet lysate than in FBS. The amount of IgG is rather high and should be considered when monoclonal antibodies are to be produced with hybridoma cells. It is possible to produce a platelet lysate medium where IgG has been removed.
As expected, platelet lysate demonstrated significant amounts of PDGF (140 pM) with no presence in FBS. It is likely that other platelet-derived growth factors are present such as PF-4, which all are beneficial for cell proliferation. The studied batch of platelet lysate and FBS showed high microbiological integrity where neither microorganisms (E. coli and S. aureus) mycoplasma nor endotoxins (<1.5 EU ml À1 ) could be detected.
Cell maintenance
The ability of the platelet lysate medium to promote growth after extended times of storage at freezing temperature (À18 C) was evaluated with Vero cells. The platelet medium showed similar growth pattern in Vero cells after 12 months of storage. The minimal cell seeding concentration was also determined with Vero-cells. After a 5-day culture with a seeding concentration of 1.6 Â 10 4 cells ml À1 (6.4 Â 10 2 cells cm À2 ) a final concentration of 3.0 Â 10 5 cells ml À1 (1.2 Â 10 3 cells cm À2 ) for platelet lysate and 3.4 Â 10 5 cells ml À1 (1.4 Â 10 3 cells cm À2 ) for FBS was achieved. A seeding density of 1.6 Â 10 4 cells ml
À1
(6.4 Â 10 2 cells cm À2 ) was the minimum that produced sustained high viability (>80%) and cell growth promotion (i.e. at least ten times inoculum).
Growth and productivity of suspension cell lines
The Sp2/0 cell line (Figure 1 ) and the 39.5 cell line ( Figure 2 ) were able to grow well at viabilities (55-80%) in platelet medium and reached cell densities in T-flasks (75 cm 2 ) of approximately 1.7 Â 10 6 cells ml À1 . FBS outperforms platelet lysate in this case even though a higher proportion of platelet lysate can approach the growth promotion of FBS. This is probably due to the fact that the tested batch of platelet lysate had been diluted. Monoclonal antibody production by 39.5 was similar in both media and reached levels of 50-70 g ml À1 supernatant (data not shown). 
Growth and productivity of adherent cell lines
As demonstrated in Figure 3 , the Hel-299 cell line showed significant growth to a high cell density (approximately 2 Â 10 6 cells ml À1 (8 Â 10 4 cells cm À2 ) after 7 days) whilst retaining higher viabilities (>80%) in platelet lysate medium than cultures with FBS (5%).
Similar results to those for Hel-299 were obtained with the HepG 2 cell line (Figure 4) where approximately 1 Â 10 6 cells ml À1 (4 Â 10 4 cells cm À2 ) was produced in ten days in platelet medium. The number of viable cells was correlated to the production of transferrin and reached levels of approximately 6 g ml À1 with platelet lysate as compared to approximately 5 g ml À1 with FBS. The transferrin production in platelet lysate was consistently higher than in FBS (data not shown). A small scaling up experiment was performed for production of transferrin in roller bottles with platelet lysate and FBS ( Figure 5 ). Again a higher production was achieved with platelet lysate (approximately 50 g ml À1 versus 15-18 g ml A lag phase was observed for the platelet medium, which can explain the discrepancy of the number of viable cells in platelet lysate as compared to FBS.
Conclusions
We have demonstrated in the present study that bovine platelet lysate can be a useful alternative to fetal bovine serum as a growth-promoting medium for animal cell culture both for suspension as well as anchorage-dependent cells. The platelet lysate contains a number of growth promoting substances including PDGF, which makes it an attractive medium for cell culture. It can be produced in large amounts at relatively low cost and without the ethical issues involved in the preparation of FBS. In this work the produced batch of platelet lysate was highly diluted compared to a typical batch of FBS. It was seen in some cell growth studies that higher concentrations of platelet lysate were required (10% of platelet lysate versus 5% FBS) to produce similar increases in viable cell numbers. Further increased concentration of platelet lysate had no appreciable effect on the performance of the medium. As platelet lysate is a biological product, batch variations should be expected and should be carefully considered in terms of variation in performance. Platelet lysate from other species such as from porcine origin should also be considered as the microbiological contamination profile is different. This is especially important in light of the bovine spongiform encephalopathy (BSE) issue affecting raw materials of bovine origin. More importantly we suggest that platelet lysate can offer substantial benefits for various applications in growing animal cells both from a perspective of performance, economy and product safety. As to a comparison with FBS, the cost-benefit picture could be favorable as platelet lysate can be produced at much less cost (25-50% of FBS) and retain similar performance as FBS.
